The last two inhalers with ozone-depleting propellants will be taken off the market by the end of this year. People with asthma and chronic obstructive pulmonary disease (COPD) who use these inhalers should discuss alternatives with their doctors before the products are phased out.
via FDA Consumer Health Information Updates http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm353701.htm
via FDA Consumer Health Information Updates http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm353701.htm
No comments:
Post a Comment